Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=959231

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. A randomized, double-blind, placebo-controlled extension trial

Author
ADACHI, Jonathan D1 ; SAAG, Kenneth G2 ; CORREA-ROTTER, Ricardo; MENKES, Charles-Joel; RODRIGUEZ-PORTALES, Jose A; SCHNITZER, Thomas J; BLOCK, Joel A; WING, Jeffrey; MCILWAIN, Harris H; WESTHOVENS, Rene; BROWN, Jacques9 ; MELO-GOMES, Jose A; DELMAS, Pierre D3 ; GRUBER, Barry L; YANOVER, Melissa J; LEITE, Maria Odette R; SIMINOSKI, Kerry G; NEVITT, Michael C; SHARP, John T; MALICE, Marie-Pierre; DUMORTIER, Thomas; CZACHUR, Michelle; CAROFANO, Wendy; LIBERMAN, Uri A4 ; DAIFOTIS, Anastasia; EMKEY, Ronald D5 ; SEEMAN, Ego6 ; LANE, Nancy E7 ; KAUFMAN, Jean-Marc8 ; POUBELLE, Patrice E. E9 ; HAWKINS, Federico
[1] McMaster University, Hamilton, Ontario, Canada
[2] University of Iowa College of Medicine, Iowa City, United States
[3] Hospital Edouard Herriot, Lyon, France
[4] Tel Aviv University, Petach Tikva, Israel
[5] Bone Research Center, West Reading, Pennsylvania, United States
[6] Austin and Repatriation Medical Center, Heidelberg, Australia
[7] The Rosalind Russell Arthritis Research Laboratories, San Francisco, California, United States
[8] Universitaire Ziekenhuizen Gent, Ghent, Belgium
[9] Le Centre Hospitalier Universitaire de Québec, Canada
A randomized, double-find, placebo-controlled extension trial
Source

Arthritis and rheumatism. 2001, Vol 44, Num 1, pp 202-211 ; ref : 28 ref

CODEN
ARHEAW
ISSN
0004-3591
Scientific domain
Rheumatology
Publisher
Wiley, Hoboken , NJ
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Acide alendronique Analyse biochimique Association Bisphosphonates Chimiothérapie Corticostéroïde Densité Diphosphonique acide dérivé Efficacité traitement Evaluation Facteur risque Fracture Homme Os Ostéoporose Prévention Spectrométrie absorption RX Toxicité Traitement Ostéopathie Système ostéoarticulaire pathologie Traumatisme
Keyword (en)
Alendronic acid Biochemical analysis Association Bisphosphonates Chemotherapy Corticosteroid Density Diphosphonic acid derivatives Treatment efficiency Evaluation Risk factor Fracture Human Bone Osteoporosis Prevention X ray absorption spectrometry Toxicity Treatment Bone disease Diseases of the osteoarticular system Trauma
Keyword (es)
Acido alendrónico Análisis bioquímico Asociación Bisfosfonatos Quimioterapia Corticoesteroide Densidad Difosfonico ácido derivado Eficacia tratamiento Evaluación Factor riesgo Fractura Hombre Hueso Osteoporosis Prevención Espectrometría absorción RX Toxicidad Tratamiento Osteopatía Sistema osteoarticular patología Traumatismo
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02U Drug toxicity and drugs side effects treatment / 002B02U08 Toxicity: osteoarticular system

Discipline
Drugs toxicity and drug intoxications Toxicology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
959231

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web